Conformational and linear epitopes on virus-like particles of human papillomavirus type 33 identified by monoclonal antibodies to the minor capsid protein L2.

The organization of epitopes on the minor capsid protein L2 of human papillomavirus (HPV) type 33 has been analysed using three monoclonal antibodies (MAbs) generated against a large fragment of the L2 protein (amino acids 82-259) expressed as a glutathione S-transferase fusion protein. The topology of the L2 epitopes has been investigated with respect to the structure of HPV-33 virus-like particles (VLPs). Two of the MAbs reacted with linear epitopes which were mapped to amino acids 153-160 and 163-170, respectively. These epitopes were accessible in denatured but not in native VLPs consisting of L1 and L2, suggesting an internal location. The third antibody was unable to detect denatured L2 protein but reacted with native VLPs. This is the first demonstration of an apparent conformational epitope of the HPV L2 protein. A model for the putative orientation of L2 in the papillomavirus capsid is deduced from the location of these and other antigenic sites.

[1]  M. Sapp,et al.  Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. , 1995, The Journal of general virology.

[2]  P. Schirmacher,et al.  Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells , 1995, Journal of virology.

[3]  J. Walboomers,et al.  Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. , 1994, The Journal of general virology.

[4]  Darren W. Henderson,et al.  Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins , 1994, Journal of virology.

[5]  R. Reichman,et al.  Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera. , 1994, The Journal of general virology.

[6]  M. Hagensee,et al.  Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids , 1994, Journal of virology.

[7]  P. Schirmacher,et al.  Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. , 1994, Virology.

[8]  D. Lowy,et al.  A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. , 1994, Journal of the National Cancer Institute.

[9]  I. Frazer,et al.  Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence , 1994, Journal of virology.

[10]  D. Lowy,et al.  Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles , 1993, Journal of virology.

[11]  M. Hagensee,et al.  HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. , 1993, Virology.

[12]  G. Grindlay,et al.  Prophylactic and therapeutic vaccination against a mucosal papillomavirus. , 1993, The Journal of general virology.

[13]  R. Garcea,et al.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles , 1993, Journal of virology.

[14]  M. Sapp,et al.  Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33 , 1993, Journal of virology.

[15]  M. Hagensee,et al.  Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins , 1993, Journal of virology.

[16]  D. Lowy,et al.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Shah,et al.  Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. , 1992, The Journal of general virology.

[18]  D. Galloway,et al.  Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11 , 1992, Journal of virology.

[19]  Y. L. Lin,et al.  Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. , 1992, Virology.

[20]  T. Baker,et al.  Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. , 1991, Biophysical journal.

[21]  I. Frazer,et al.  Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. , 1991, Virology.

[22]  R. Burk,et al.  Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins. , 1991, Virology.

[23]  N. Christensen,et al.  The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes. , 1991, Virology.

[24]  D. Galloway,et al.  Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18 , 1991, Journal of virology.

[25]  M. Dunn,et al.  Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions , 1991, Journal of virology.

[26]  N. Christensen,et al.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11 , 1990, Journal of virology.

[27]  D. Galloway,et al.  Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins. , 1990, Virology.

[28]  E. de Villiers Heterogeneity of the human papillomavirus group , 1989, Journal of virology.

[29]  E. Villiers Heterogeneity of the human papillomavirus group. , 1989 .

[30]  A. B. Jenson,et al.  Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies. , 1989, The Journal of general virology.

[31]  P. Lake,et al.  Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies. , 1987, Journal of the National Cancer Institute.

[32]  J. Doorbar,et al.  Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a , 1987, Journal of virology.

[33]  H. Shirasawa,et al.  Expression of the human papillomavirus type 6b L2 open reading frame in Escherichia coli: L2-beta-galactosidase fusion proteins and their antigenic properties. , 1987, Virology.

[34]  F. Breitburd,et al.  The L2 open reading frame of human papillomavirus type 1a encodes a minor structural protein carrying type-specific antigens , 1986, Journal of virology.

[35]  S. Cole,et al.  Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer , 1986, Journal of virology.

[36]  C. Milstein,et al.  Antibodies to major histocompatibility antigens produced by hybrid cell lines , 1977, Nature.